FDA greenlights COVID-19 booster vaccine for some immunocompromised patients
August 12, 2021 at 23:35 PM EDT
The FDA authorized a COVID-19 booster shot for certain immunocompromised patients after evidence indicated a weak immune response following the initial two-dose series.
